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Abstract. – OBJECTIVES, Oxidative stress
is increasingly recognised as a pivotal factor
that plays a number of roles in the inflammatory
response to environmental signals. It has been
claimed that Aesculus hippocastanum extracts
have antioxidant and anti-inflammatory activity,
but these claims are mainly based on the results
of chemical reactions and folk-medicine.
MATERIALS AND METHODS, The aim of this
study was to examine whether a bark extract of
Aesculus hippocastanum interferes with reactive
oxygen/nitrogen species (ROS/RNS) during the
course of human neutrophil respiratory bursts,
and to establish the lowest concentration at
which it still has antioxidant activity by means of
luminol amplified chemiluminescence (LACL). We
also studied its ability to counteract lipid peroxi-
dation (LPO) in human cells. Before investigating
its antioxidant effects on human cells, we
analysed its scavenging activity against ABTS•+,
hydroxyl radical, superoxide anion, and Fremy’s
salt (those last three by means of electron para-
magnetic resonance (EPR) spectrometry).
RESULTS, The extract of Aesculus hippocas-
tanum exerted its anti-ROS/RNS activity in a
concentration-dependent manner with signifi-
cant effects being observed for even very low
concentrations: 10 µg/ml without L-Arg, and 5
µg/ml when L-Arg was added to the fMLP test.
The LPO assay confirmed these results, which
were paralleled by the EPR study.
CONCLUSIONS, These findings are interest-
ing for improving the antioxidant network and
restoring redox balance in human cells, and ex-
tend the possibility of using plant-derived mole-
cules to antagonise the oxidative stress generat-
ed in living organisms when the balance is in
favour of free radicals as a result of the deple-
tion of cell antioxidants.
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Introduction
The catalytic action of a number of enzymes
and electron transport processes involve a one-
electron transfer that yields free radical interme-
diates and reactive oxygen species (ROS) in a
wide range of biological processees1. Moderate
concentrations of ROS play an important role as
regulatory mediators in signal transduction
processes and major cellular events (e.g. the tran-
scriptional activation of nuclear factor kB, nor-
mal cell growth, gene expression, cellular prolif-
eration, cellular senescence, and programmed
cell death)2-4. An excessive amount of ROS may
arise from excessive neutrophil burst release or
less well regulated sources such as the mitochon-
drial electron transport chain or the exogenous
sources. If these excess is not balanced by en-
dogenous antioxidant defences a oxidative stress
can induce pathological situations (e.g. inflam-
mation, mutation, carcinogenesis, aging, etc.)4,5
that give rise to various diseases6. Oxygen is an
unusual molecule in that it has two unpaired
electrons with parallel spins (biradical). In order
to overcome spin restriction, oxygen prefers to
accept electrons one at a time, and the sequential
addition of electrons leads to the formation of
ROS7. Because of the ubiquity of molecular oxy-
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Italy), and the identification was done according
to the monography “Aesculum hippocastanum ex
cortice, ethanol decoctum”, S. Benynes, German
Homeopathic Pharmacopoeia, RWS Group, Lon-
don, 2000, sect.1/3A. The raw material used for
the extraction consisted in fragments (1-3 cm) of
Aesculus hippocastanum bark collected in spring
and autumn, which was dried and minced, placed
in a steel container, and submerged in a solution
of water and ethanol (30:70%) at a temperature
of 37°C for 24 hours. The mixture was filtered
and concentrated at a temperature of 65°C under
vacuum at 70 cm Hg, and then dried by means of
a spray dryer. On the extract were determined the
total phenolic compound levels (Folin-Ciocal-
teau’s reagent)13, the total flavonoids14, and
proanthocyanidins15.
Scavenging of ABTS •+
The free radical scavenging capacity of vari-
ous extract concentrations (80 µg/ml to 2.5
µg/ml) was studied using the ABTS radical
cation decolorisation assay, which is based on the
reduction of ABTS•+ radicals by antioxidants of
the plant extract tested. We used the method of
Re et al16. Briefly, ABTS (Sigma Chemical Co.,
MO, USA) was dissolved in deionised water to a
7 mM concentration, and ABTS radical cation
(ABTS•+) was produced by reacting the ABTS
solution (1 mL) with 2.45 mM potassium persul-
fate (10 µL) (Sigma) and leaving the mixture
(stock solution) in the dark at room temperature
for 12-16 h to give a dark blue solution. For this
study, the ABTS•+ solution was diluted in
deionised water to an absorbance of 0.700
(±0.020) at 734 nm, and an appropriate solvent
blank reading was made (AB). An aliquot of the
test sample (100 µL) was mixed with ABTS•+ so-
lution (900 µL) in a 1 ml cuvette, and its adsor-
bance was recorded for 15 min (AE). All of the
solutions were used on the day of preparation,
and all of the determinations were carried out in
duplicate. The percentage inhibition of ABTS•+
was calculated using the formula:
% inhibition = [(AB-AE)/AB] × 100
Electron Paramagnetic Resonance
(EPR) Spectrometry
EPR spectrometry was used to investigate the
antiradical activity of various compounds. By de-
finition, a free radical is a species containing an
unpaired electron and, therefore, paramagnetic.
This property forms the basis of the physical de-
gen in aerobic organisms, and the fact that it
readily accepts electrons, oxygen-centred free
radicals are continuously produced8.
In order to decrease oxidative stress (for ex-
ample during over-regulated human polymor-
phonuclear neutrophil (PMN) respiratory bursts
and the associated inflammation) a rational strat-
egy is to remove the starting cause: i.e. the spe-
cific toxic effector molecules. However, this is
frequently difficult and an alternative is to in-
crease antioxidant defences by administering
agents with antioxidant activity8-10.
This second approach offers more practical
therapeutic possibilities and various antioxidant
molecules are available. However, only a few
have been adopted in clinical practice and, nowa-
days, there is a growing interest in the biochemi-
cal functions of natural vegetable, fruit, and med-
icinal plant extracts endowed with antioxidant
activity, which are being increasingly used in
specific antioxidant formulations or alimentary
integrators.
It has been claimed that Aesculus hippocas-
tanum extracts have antioxidant and anti-inflam-
matory activity11,12, mainly on the basis of the re-
sults of chemical reactions and folk medicine
that are not always completely reliable because
of the lack of a control drug and variability. For
example, it is still unclear whether they are capa-
ble of antagonising the oxidative burden released
by human PMNs during respiratory bursts, one
of the main sources of oxidant radicals.
The aim of this study was to examine whether
a bark extract of Aesculus hippocastanum inter-
feres with ROS and RNS during the course of
human PMN respiratory bursts, and to establish
the lowest concentration at which it still has an-
tioxidant activity by means of luminol amplified
chemiluminescence (LACL). We also studied its
ability to counteract lipid peroxidation (LPO) in
human cells. Before investigating its antioxidant
effects on human cells, we analysed its scaveng-
ing activity against ABTS•+, hydroxyl radical
(HO•), superoxide anion (O2•¯), and Fremy’s salt
(the last three by means of electron paramagnetic
resonance (EPR) spectrometry).
Materials and Methods
Plant Material and Extraction
A commercial preparation of a hydro-alcoholic
extract of Aesculus hippocastanum was obtained
from EPO (Estratti Piante Officinali, srl, Milan,
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tection of free radicals by EPR, whereby the
magnetic moment exerted by the unpaired elec-
tron is detected17. EPR not only allows the direct
detection of free radicals, but also detects the ac-
tivity of molecules with antiradical activity17.
Fenton Reaction Model System with
EPR Detection of Hydroxyl Radical (HO •)
The first series of tests used the spin trapping
method18, which is based on the rapid reaction
of many radicals with certain chemical acceptor
molecules (spin trapping agents) to produce
more stable secondary radicals. The diamagnet-
ic spin trap nitrone DMPO (5,5-dimethyl-1-
pyrrolidine-N-oxide) (Sigma) was added to the
reaction mixture to produce the relatively long-
lived free radical products DMPO-OH, which
can be easily investigated by EPR. The activity
of the Aesculus hippocastanum extract (from 80
µg/ml to 2.5 µg/ml) was evaluated by assessing
its ability to scavenge the hydroxyl radical
(HO•), the most potent active oxygen species19.
To obtain the Fenton reaction, the final concen-
trations were: FeSO4 • 7H2O 0.31 mM/L (Sig-
ma), 2Na EDTA 0.34 mM/L (Sigma) and H2O2
0.31 mM/L (Sigma) and DMPO 0.78 mM/L
(Sigma). The Fenton reaction was initiated by
mixing the Fe-EDTA solution with the extract
or phosphate buffered saline (PBS) (0.1 mM/L,
pH 7.4) (control), and then adding the H2O2 so-
lution. The hydroxyl radical generated by a
standard Fenton reaction was trapped using
DMPO as previously described20,21 with slight
modifications.
The solutions were carefully mixed in a glass
tube and then placed in a 100 µl capillary tube
for EPR analysis. The EPR spectra were
recorded after exactly 1 min. The resulting
DMPO-OH (consisting of a quartet of reso-
nances with 1:2:2:1 relative intensities) was de-
tected using an X-band EPR spectrometer
(mod. Miniscope MS 200, Magnettech, Berlin,
Germany), whose parameters were: field modu-
lation 100 KHz, modulation amplitude 2000
mG, field constant 60 s, centre field 3349.39 G,
sweep width 99.70 G, X-band frequency 9.64
GHz, attenuation 7, and gain 100. The percent-
age HO• scavenging activity of the assayed so-
lution was expressed by means of the formula:
100•(h0- hX)/h0 [%], where hx and ho are the rel-
ative heights of the highest resonance signal
(mm) of the DMPO-OH adduct spectra in a re-
action mixture without and with the Aesculus
hippocastanum extract.
KO2 in Crown-Ether as a Source of
Superoxide Anion (O2¯•)
In the second series of tests, the EPR analysis
was based on the spin trapping of the superoxide
radical (O2•¯) generated by potassium superoxide
(KO2) in dimethylsulpxide (DMSO) with the ad-
dition of 18-crown-6-ether to complex K+ be-
cause, under these conditions, a DMPO-OOH
adduct is observed21,22. A typical reaction mixture
contained 7.29 mM/L KO2 (Sigma), 9.013 mM/L
crown-ether (Sigma) in DMSO and 14.29 mM/L
DMPO (Sigma), and the effects of the same
amounts of the extract as in the previous test
were investigated.
The reaction mixture was stirred and trans-
ferred into a 100 µl capillary tube for EPR analy-
sis, and the EPR spectra were recorded after ex-
actly 30 sec. The resulting DMPO-OOH was de-
tected using an X-band EPR spectrometer (mod.
Miniscope MS 200, Magnettech, Berlin, Ger-
many), whose parameters were: field modulation
100 KHz, modulation amplitude 2500 mG, field
constant 45 s, centre field 3349.39 G, sweep
width 147.76 G, X-band frequency 9.64 GHz, at-
tenuation 7, and gain 800. The intensity of EPR
was expressed by means of the formula: 100•(h0-
hX)/h0 [%], where hx and ho are the relative
heights of the highest resonance signal (mm) of
the DMPO-OOH adduct spectra in a reaction
mixture without and with the extract.
EPR Assay Based on the Reduction of
Fremy’s Salt Radical
A third series of tests were performed using
Fremy’s salt (potassium nitrosodisulfonate or
[(KSO3)2NO]), a persistent water-soluble radi-
cal22. A typical reaction mixture contained 2.5
µM/L of Fremy’s salt (Sigma), 0.1 M/L phos-
phate buffer, and the same amounts of the extract
as in the previous tests.
The mixture was stirred and transferred into
100 µl glass capillary tube, and the EPR spectra
were recorded after 15 min at room temperature
using a spectrometer (mod. Miniscope MS 200,
Magnettech, Berlin, Germany), operating on the
X-band. The typical instrument settings were:
field modulation 100 KHz, modulation amplitude
2000 mG, field constant 60 s, centre field
3350.27 G, sweep width 99.70 G, X-band fre-
quency 9.64 GHz, attenuation 7, and gain 100.
The intensity of the EPR signal was measured at
the height of the first line. The scavenging activi-
ty of the extract was defined as 100•(h0-hX)/h0
[%], where h0 is the height of the first line in the
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4EPR spectrum of Fremy’s free radicals in the
blank, and hX the height of the first line in the
EPR spectrum of Fremy’s free radicals in the
presence of the extract.
Human PMN Harvesting
Peripheral venous blood (5 ml) drawn from
healthy adult donors was stratified on 3 ml of a
Polymorphprep cell separation medium (Sentinel
Ch., Milan, Italy), and the PMNs were separated
by means of density gradient centrifugation. Af-
ter centrifugation, the upper mononuclear cell
band was discarded, and the lower PMN band
was washed in RPMI 1640 medium containing
glutamine (Sigma). When necessary, any residual
erythrocytes in the granulocyte preparation were
lysed using a 0.15 mol/l NH4Cl solution (pH
7.4). After the aggregates were disrupted by be-
ing passed through a needle with an internal di-
ameter of 150 µm, the PMNs were collected,
washed in Hank’s buffered salt solution (HBSS),
and tested for viability by means of Trypan blue
exclusion. The number of cells in the final cell
suspension used for each test was adjusted by
counting in a Burker chamber by means of a mi-
croscope Olympus, mod BH2, Milan, Italy (with
interference contrast equipment).
Measurement of Oxidative Burst
Responses by Luminol Amplified
Chemiluminescence (LACL)
This method has been widely used to detect the
PMN production of ROS/RNS under various con-
ditions23-25. In order to yield light, luminol has to
undergo two-electron oxidation and form an un-
stable endoperoxide, which decomposes to an ex-
cited state (3-aminophthalic acid), and then relax-
es to the ground state by emitting photons26,27 that
are amplified by the phototube of a luminometer.
PMN oxidative bursts are associated with the gen-
eration of superoxide anions, hydrogen peroxide,
oxygen radicals, hydroxyl radicals and hypochlor-
ous acid (ROS). As luminol degradation by ROS
is associated with luminescence, the inclusion of
luminol in the reaction medium provides a sensi-
tive means of detecting PMN respiratory bursts.
LACL was investigated using the soluble stim-
ulants N-formyl-methionyl-leucyl-phenylalanine
(fMLP) which is a bacterial tripeptide that is fre-
quently used to stimulate PMN respiratory bursts
and acts via a specific receptor.
The measurements were made using a slightly
modified version of the procedure described by
Briheim and Dahlgren23.
Briefly, 0.1 ml of a PMN suspension (1x106
cells/ml ) plus 0.2 ml of 2 × 10-5 mol/l of luminol
(Sigma) were put into a 3 ml flat-bottomed poly-
styrene vial. The vial was placed in the light-
proof chamber of a luminometer (mod.1250, Bio
Orbit, Luminometer, Turku, Finland), and the
carousel was rotated to bring the sample in line
with the photomultiplier tube in order to record
background activity. Subsequently, fMLP 5x10-7
mol/l was added to reach a final volume of 1 ml,
and the resulting light output was continuously
recorded in millivolts on a chart recorder and si-
multaneously by means of a digital printout set to
record intervals of 1-10 sec. All of the con-
stituents of the mixture were kept at 37°C during
the reaction by passing water from a thermostati-
cally controlled circulation system through a pol-
ished hollow metal sample holder. No mixing
took place during the recordings. The gain con-
trol was set to give a recording of 10 mV for a
built-in standard. A background subtraction con-
trol zeroed the instrument before the addition of
fMLP. The LACL response patterns were identi-
fied by calculating peak values (mV) and the
times to peak values (min, sec). The effect of the
Aesculus hippocastanum extract was evaluated at
concentrations ranging from 80 µg/ml to 2.5
µg/ml. The incubation time was 15 min at 37°C.
A second series of human PMN tests was per-
formed in the same way, but L-Arg (170 µg/ml)
(Sigma) was added to the medium incubating the
PMNs as a NO donor in order to be able to read
the NO-derived peroxynitrite radical by means of
LACL.
In these tests, the effects of the extract were
evaluated at concentrations ranging from 80
µg/ml to 2.5 µg/ml. The incubation time was 15
min at 37°C.
Lipid Peroxidation (LPO) Measurement
The A549 human lung carcinoma epithelial-
like cell line was obtained from the ATCCC
(American Type Cell Culture Collection). The
cells were cultured in RPMI-1640 medium sup-
plemented with 1% penicillin-streptomycin,
0.8% pyruvic acid, 2 mM L-glutamine and 10%
heat-inactivated fetal bovine serum (FBS) in
100 mm plastic tissue culture dishes, and main-
tained in a humidified atmosphere at 37°C and
5% CO2.
Exposure was started at 80% confluence. An-
tioxidant treatment was done prior to oxidant ex-
posure. The cells were first treated with different
concentrations of the extract for 10 min at 37°C,
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5% CO2, and then hydrogen peroxide solution (4
mM, also used as positive control) was added for
two hours, under the same cell growth condi-
tions. Lipid peroxidation was assessed using the
thiobarbituric acid reactive substances (TBARS)
assay, which mainly detects malondialdehyde
(MDA), an end-product of the peroxidation of
polyunsatured fatty acids and related esters.
TBARS was measured by using a slightly modi-
fied version of the method of Ahamed et al28. The
cells were grown in 100 mm tissue culture dishes
to approximately 80% confluency, and after
treatment, the medium was removed and the cells
were washed with PBS. The cell suspension was
lysed in liquid nitrogen and then homogenised in
ice-cold PBS. One millilitre of TBARS solution
(0.375% TBA, 20% TCA, 25% HCl 1N) was
added to the samples, which were incubated for
30 min to 70°C, cooled in ice and then cen-
trifuged at 10,000 g for 5 min. The absorbance of
the supernatants (i.e. the absorbance of TBARS)
was measured spectrophotometrically at 532 nm.
The concentration of TBARS was determined us-
ing a standard curve of MDA obtained from the
acid hydrolysis of tetraethoxypropane (TEP).
The results were normalised against protein lev-
els in each sample, as measured using the
method of Lowry et al29, and expressed as nmol
of MDA/mg of cell protein.
Statistical Analysis
Four assays of each concentration were made
in each test, and the statistical significance of the
differences was calculated by means of one-way
ANOVA followed by multiple paired compar-
isons using Dunnett’s test. The differences were
considered statistically significant when the p
value was ≤ 0.05.
Results
The effects of the bark extract of Aesculus hip-
pocastanum on the reduction in ABTS•+ radicals
are shown in Figure 1; the lowest concentration
that was still active was 5 µg/ml. From this con-
centration to 80 µg/ml (the highest concentration
investigated), there was a significant concentra-
tion-dependent inhibition of ABTS•+ radicals
(from 96.54 ± 1.27% to 16.91 ± 0.64%)
The EPR adduct DMPO-OH was significantly
reduced by the bark extract at concentrations
ranging from 80 µg/ml to 20 µg/ml (from 48.66
± 2.74% to 21.98 ± 1.25%) (Figure 2).
Figure 3 shows representative spectra of the
adduct DMPO-OOH (from KO2+crown-ether).
There was a significant reduction at bark extract
concentrations ranging from 20 µg/ml to 80
µg/ml (from 25.58 ± 3.68% to 56.31 ± 2.60%)
(Figure 3).
The isotropic spectrum of Fremy’s salt consists
of three single narrow peaks that arise from the
interaction of the unpaired electron spin with the
nuclear spin of nitrogen. This triple resonance
was significantly reduced at bark extract concen-
trations ranging from 80 µg/ml to 10 µg/ml (from
93.00 ± 1.22% to 22.19 ± 3.48%) (Figure 4).
From a general point of view, all of these find-
ings showed the presence of scavenging activity,
with the relative intensity varying depending on
the type of radical.
Microscopic examination of the neutrophil
suspensions showed that the population of neu-
trophils was always ≥95%, and the viability de-
termined by means of trypan blue dye exclusion
was always ≥94%. None of the concentrations of
the Aesculus hippocastanum extract used in the
fMLP tests affected PMN viability. Figure 5
shows the effects of the various Aesculus hip-
pocastanum extract concentrations on the LACL
of fMLP-induced PMN respiratory bursts. The
lowest concentration that still had significant an-
tioxidant activity was 10 µg/ml. From this con-
centration to 80 µg/ml (the highest concentration
investigated), there was a significant concentra-
tion-dependent inhibition of peak chemilumines-
cence. The times to peak chemiluminescence
were generally similar at the various concentra-
tions, and were not significantly different from
those of the controls.
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Figure 1. Effects of various concentrations of Aesculus
hippocastanum extract on ABTS radical cation (ABTS•+)
(** = p ≤ 0.01; * = p ≤ 0.05).
6When L-Arg was added to the reaction medi-
um as a NO donor, baseline LACL increased ap-
proximately 3-4 times. The inhibiting behaviour
of the same concentrations of Aesculus hippocas-
tanum under these new conditions was con-
firmed, and parallelled those previously obtained
with fMLP without the addition of L-Arg to the
medium. The lowest concentration that signifi-
cantly reduced LACL was 5 µg/ml; from that to
80 µg/ml, the concentration-dependent inhibition
of peak chemiluminescence was significant (Fig-
ure 6). The time to peak LACL was not signifi-
cantly different from that of the controls.
The findings of lipoperoxidation (LPO) test
are shown in Figure 7. Exposure of A549 cells to
H2O2 (4 mM for two hours) increased lipid per-
P.C. Braga, L. Marabini, Y.Y. Wang, N. Lattuada, R. Calò, A. Bertelli, et al.
Figure 2. Effects of various amounts of Aesculus hippocastanum extract on the HO• radical. Panel A: Percentage quenching
effect of various amounts of the extract using DMPO to trap the HO• radical (** = p ≤ 0.01; * = p ≤ 0.05). Panel B: Examples
of EPR spectra: A = control; B-G = effects of concentrations ranging from 80 µg/mL to 2.5 µg/mL.
Figure 3. Effects of various amounts of Aesculus hippocastanum extract on the O2–• radical. Panel A: Percentage quenching
effect of various amounts of the extract using DMPO to trap the O2–• radical (** = p ≤ 0.01; * = p ≤ 0.05). Panel B: Examples of
EPR spectra: A = control; B-G = effects of concentrations ranging from 80 µg/mL to 2.5 µg/mL.
oxidation membranes at TBARS levels of 214%
in comparison with control value. Pretreatment
with 80 and 40 µg/ml extract significantly inhib-
ited the induced damage.
Discussion
Despite the presence of a cellular antioxidant
defence system to counteract the oxidative dam-
age caused by ROS, oxidative damage accumu-
lates during the life cycle because of radical-relat-
ed damage to DNA, proteins and lipids. The role
of free radicals is, therefore, gaining increasing at-
tention as so many pathological phenomena are
related to changes in cell redox status. The oxida-
tive stress-activated signalling cascade upregulates
the genes controlling inflammatory processes5,
and so reducing oxidative stress by controlling
ROS or RNS levels using plant extracts with an-
tioxidant activity, means interferring with the sig-
nal transduction pathways of inflammation.
It has been experimentally documented that
Aesculus hippocastanum extract has protective
7
Aesculus hippocastanum L. bark extract protects against oxidative damage
Figure 4. Effects of various amounts of Aesculus hippocastanum extract on Fremy’s salt radical (*** = p ≤ 0.001; ** = p ≤
0.01). Panel A: Percentage quenching effect of various amounts of the extract to trap the Fremy’s salt radical. Panel B: Exam-
ples of EPR spectra: A = control; B-G = effects of concentrations ranging from 80 µg/mL to 2.5 µg/mL.
Figure 5. Effects of various concentrations of Aesculus
hippocastanum extract on the LACL of PMN respiratory
bursts induced by fMLP (** = p ≤ 0.01; * = p ≤ 0.05).
Figure 6. Effects of various concentrations of Aesculus
hippocastanum extract on the LACL of PMN respiratory
bursts induced by fMLP after L-Arg incubation (** = p ≤
0.01).
8veinotonic, antiedemigenic, and anti-inflammato-
ry activity30-35, particularly on the microcircula-
tion. Clinically, extracts have been used to treat
venous stasis and venous insufficiency36-40. Our
findings show that Aesculus hippocastanus bark
extract has interesting concentration-dependent
antioxidant activity, confirmed by EPR, and the
scavenging of ABTS•+. Our findings are in line
with the activity described by other Authors30,40,
but extend our knowledge (never previously in-
vestigated) of the smallest scavenging concentra-
tion still capable of counteracting the hydroxyl
radical (HO•), the superoxide anion (O2•¯), Fre-
my’s salt, and ABTS•+ radical: respectively 20,
20, 10 and 5 µg/ml. In addition, our LACL find-
ings concerning the effects of Aesculus hippocas-
tanum extract on human PMNs (never previously
investigated), whose respiratory bursts release a
considerable burden of ROS and RNS, show that
they are still present in human cells at concentra-
tion-dependent manner (confirmed also by LPO
data). They further extend our knowledge by in-
dicating that the extract exerts its anti-ROS and
anti-RNS (peroxynitrite) activity in a concentra-
tion-dependent manner and has significant ef-
fects at even very low concentrations: 10 µg/ml
for the test without L-Arg and respectively 5
µg/ml when L-Arg was added to the fMLP tests.
As the aim of the study was to characterize the
antioxidant activity of Aesculus hippocastanum
bark extract (mainly on human PMNs, one of the
main sources of oxidant radicals), we did not in-
vestigate the effects of the individual molecules
present in the extract. However, the anti-oxidant
and the anti-inflammatory properties (which are
interconnected) of Aesculus hippocastanus bark
extract are mainly attributable to their secondary
metabolites content: total phenolic compound
level 381.3 mg/g (eq.rutine), total flavonoids
150.8 mg/g, total amount escine 122.5 mg/g, and
proanthocyanidins 11.5 mg/g.
Conclusions
Our findings are interesting for improving the
antioxidant network and restoring redox balance
to human cells, and extend our possibility of us-
ing plant-derived molecules to antagonise the ox-
idative stress generated in living organisms when
the balance is in favour of free radicals as a result
of the depletion of cell antioxidants.
The anti-oxidant and anti-inflammatory effects
of Aesculus hippocastanum bark extract seem to
be clear, but its molecular mechanisms have not
yet been fully investigated. Its effects on the
arachidonic acid cascade, serine proteases, pro-
tein kinase C and the nuclear factor-kB (NFkB)
signalling pathway should be further elucidated
in order to complete the anti-oxidant and anti-in-
flammatory profile.
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